Skip to content

Opening book details…

Can I read POS1213 IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN ON WELLBEING ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) on EtoBox?

POS1213 IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN ON WELLBEING ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) by M. Garrido-Cumbrera; H. Marzo-Ortega; L. Christen; L. Carmona; J. Correa-Fernández; S. Sanz-Gómez; P. Plazuelo-Ramos; L. Grange; D. Webb; S. Irwin; C. Jacklin; S. Makri; E. Mateus; S. Mingolla; K. Antonopoulou; V. Navarro-Compán is a Medicine article available to read on EtoBox.

What is POS1213 IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN ON WELLBEING ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) about?

## Background: The COVID-19 pandemic has impacted the wellbeing of patients with Rheumatic and Musculoskeletal Diseases (RMDs). ## Objectives: The aim is to assess emotional well-being and its associated factors in patients with RMDs during the first wave of the COVID-19 pandemic. ## Methods: REUMAVID is an international collaboration led by the Health & Territory Research group at the University of Seville, together with a multidisciplinary team including patient organisations and rheumatologists. This cross-sectional study consisting of an online survey gathering data from patients with a diagnosis of 15 RMDs in Cyprus, France, Greece, Italy, Portugal, Spain, and the United Kingdom. 1,800 participants were recruited by patient organisations. Data was collected between April and July 2020. Participants were divided into two groups: 1) Participants with poor wellbeing (World Health Organization-Five Wellbeing Index (WHO-5) ≤ 50), 2) Participants with good wellbeing (WHO-5 >50). The Mann-Whitney and χ^2^ tests were used to analyse possible relations between sociodemographic characteristics, lifestyle, and outdoor contact with wellbeing during the first wave of the COVID-19 pandemic.

Who reads POS1213 IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN ON WELLBEING ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1)?

It is typically read by researchers, students, and practitioners in Medicine.

Author
M. Garrido-Cumbrera; H. Marzo-Ortega; L. Christen; L. Carmona; J. Correa-Fernández; S. Sanz-Gómez; P. Plazuelo-Ramos; L. Grange; D. Webb; S. Irwin; C. Jacklin; S. Makri; E. Mateus; S. Mingolla; K. Antonopoulou; V. Navarro-Compán
Publisher
BMJ
Published
2021
Language
EN
Field
Medicine (Health Sciences)

More by M. Garrido-Cumbrera; H. Marzo-Ortega; L. Christen; L. Carmona; J. Correa-Fernández; S. Sanz-Gómez; P. Plazuelo-Ramos; L. Grange; D. Webb; S. Irwin; C. Jacklin; S. Makri; E. Mateus; S. Mingolla; K. Antonopoulou; V. Navarro-Compán

Browse all works by M. Garrido-Cumbrera; H. Marzo-Ortega; L. Christen; L. Carmona; J. Correa-Fernández; S. Sanz-Gómez; P. Plazuelo-Ramos; L. Grange; D. Webb; S. Irwin; C. Jacklin; S. Makri; E. Mateus; S. Mingolla; K. Antonopoulou; V. Navarro-Compán